Invention Grant
US08808697B2 Methods of use of soluble CD24 for therapy of rheumatoid arthritis
有权
使用可溶性CD24治疗类风湿性关节炎的方法
- Patent Title: Methods of use of soluble CD24 for therapy of rheumatoid arthritis
- Patent Title (中): 使用可溶性CD24治疗类风湿性关节炎的方法
-
Application No.: US13643527Application Date: 2011-04-28
-
Publication No.: US08808697B2Publication Date: 2014-08-19
- Inventor: Xincheng Zheng , Wei Wu , Yang Liu , Pan Zheng
- Applicant: Xincheng Zheng , Wei Wu , Yang Liu , Pan Zheng
- Applicant Address: US MD Rockville
- Assignee: Oncoimmune, Inc.
- Current Assignee: Oncoimmune, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Polsinelli PC
- Agent Teddy C. Scott, Jr.; Ron Galant
- International Application: PCT/US2011/034282 WO 20110428
- International Announcement: WO2011/139820 WO 20111110
- Main IPC: C07K14/435
- IPC: C07K14/435 ; C07K14/705 ; C07K16/46
Abstract:
Provided herein is a method of treating rheumatoid arthritis using a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.
Public/Granted literature
- US20130136739A1 METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS Public/Granted day:2013-05-30
Information query
